Abstract: The present invention relates to methods for providing cytoplasmic male sterile Petroselinum plants, cytoplasmic male sterile Petroselinum crispum plants and to seeds, cells, tissues and plant parts thereof. Specifically the present invention relates to a method for providing a cytoplasmic male sterile Petroselinum crispum plant comprising: (a) providing first protoplasts obtained from a plant selected from the group consisting of Daucus carota L., Foeniculum vulgare Mill., Apium graveolens L., and Pastinaca sativa L., wherein the first protoplasts have a substantially inactivated nuclear genome and a substantially non-modified cytoplasm; (b) providing second protoplasts obtained from Petroselinum crispum wherein the second protoplasts have a substantially inactivated cytoplasm and a substantially non-modified nuclear genome; (c) fusing said first and second protoplasts; and (d) obtaining from the fusion product of said first and second protoplasts a cytoplasmic male sterile Petroselinum crispum plant.

Abstract: The present invention relates to cytoplasmic male sterile (CMS) Cichorium plants and especially to cytoplasmic male sterile (CMS) green chicory plants; cytoplasmic male sterile (CMS) radicchio rosso plants; cytoplasmic male sterile (CMS) red leaved chicory plants, cytoplasmic male sterile (CMS) Treviso plants, cytoplasmic male sterile (CMS) white chicory plants, cytoplasmic male sterile (CMS) sugar loaf plants, cytoplasmic male sterile (CMS) Belgian endive plants, cytoplasmic male sterile (CMS) witloof plants, cytoplasmic male sterile (CMS) Catalogna plants, cytoplasmic male sterile (CMS) C. intybus var. foliosum plants, cytoplasmic male sterile (CMS) C. endivia plants and cytoplasmic male sterile (CMS) C. intybus L. var. sativum plants. The present invention further relates to methods for identifying cytoplasmic male sterile (CMS) Cichorium plants and mitochondrial nucleic acid sequences providing cytoplasmic male sterility (CMS) in Cichorium plants.

Abstract: The present invention relates to cytoplasmic male sterile (CMS) Cichorium plants and especially to cytoplasmic male sterile (CMS) green chicory plants; cytoplasmic male sterile (CMS) radicchio rosso plants; cytoplasmic male sterile (CMS) red leaved chicory plants, cytoplasmic male sterile (CMS) Treviso plants, cytoplasmic male sterile (CMS) white chicory plants, cytoplasmic male sterile (CMS) sugar loaf plants, cytoplasmic male sterile (CMS) Belgian endive plants, cytoplasmic male sterile (CMS) witloof plants, cytoplasmic male sterile (CMS) Catalogna plants, cytoplasmic male sterile (CMS) C. intybus var. foliosum plants, cytoplasmic male sterile (CMS) C. endivia plants and cytoplasmic male sterile (CMS) C. intybus L. var. sativum plants. The present invention further relates to methods for identifying cytoplasmic male sterile (CMS) Cichorium plants and mitochondrial nucleic acid sequences providing cytoplasmic male sterility (CMS) in Cichorium plants.

Abstract: The present invention relates to methods for providing cytoplasmic male sterile Petroselinum plants, cytoplasmic male sterile Petroselinum crispum plants and to seeds, cells, tissues and plant parts thereof. Specifically the present invention relates to a method for providing a cytoplasmic male sterile Petroselinum crispum plant comprising: (a) providing first protoplasts obtained from a plant selected from the group consisting of Daucus carota L., Foeniculum vulgare Mill., Apium graveolens L., and Pastinaca sativa L., wherein the first protoplasts have a substantially inactivated nuclear genome and a substantially non-modified cytoplasm; (b) providing second protoplasts obtained from Petroselinum crispum wherein the second protoplasts have a substantially inactivated cytoplasm and a substantially non-modified nuclear genome; (c) fusing said first and second protoplasts; and (d) obtaining from the fusion product of said first and second protoplasts a cytoplasmic male sterile Petroselinum crispum plant.

Abstract: The invention relates to a serum protein product, suitable as an ingredient for foods and therapeutic compositions, in particular infant and baby foods. The invention also provides a method for the preparation of the serum protein product, based on micro filtration of milk. The invention provides a method for the preparation of a serum protein product, comprising the preparation of a permeate through micro filtration of cow's milk at a temperature of between 10 and 20° C. utilizing a membrane having a pore size of between 0.3 and 0.5 ?m.

Abstract: The invention relates to a serum protein product, suitable as an ingredient for foods and therapeutic compositions, in particular infant and baby foods. The invention also provides a method for the preparation of the serum protein product, based on micro filtration of milk. The invention provides a method for the preparation of a serum protein product, comprising the preparation of a permeate through micro filtration of cow's milk at a temperature of between 10 and 20° C. utilizing a membrane having a pore size of between 0.3 and 0.5 ?m.

Abstract: The invention relates to a serum protein product, suitable as an ingredient for foods and therapeutic compositions, in particular infant and baby foods. The invention also provides a method for the preparation of the serum protein product, based on micro filtration of milk. The invention provides a method for the preparation of a serum protein product, comprising the preparation of a permeate through micro filtration of cow's milk at a temperature of between 10 and 20° C. utilizing a membrane having a pore size of between 0.3 and 0.5 ?m.

Abstract: The invention relates to foods, such as infants and children's food and dietary supplements for infants and children. The invention provides a composition comprising a lipid source, a carbohydrate source and a protein source, characterized in that the composition further contains the B. lactis strain deposited under ATCC number 27536 and the L. casei strain deposited under ATCC number 55544. Such a composition contributes to the general resistance, in particular with respect to undesired passage of pathogens and the incidence of respiratory diseases in children.

Abstract: The invention relates to a concentrated or dried milk product having cholesterol-lowering effects and to methods for preparing the same. Provided is a process for the preparation of a milk concentrate or milk powder having a cholesterol-lowering effect, comprising :—preparing a milk liquid;—preparing a fat fraction comprising at least one sterol; and—subjecting the milk liquid to an evaporation procedure, during which procedure the fat fraction is added to the milk liquid before, in or after the liquid collector of one or more effects of the evaporator. Also provided is the product obtainable thereby.

Abstract: A method for treatment for deterioration of a mucosal barrier, an intestinal dysfunction or injury, suboptimal intestinal wall maturation of new-borns, undernutrition, suboptimal intestinal blood flow, allergy, sepsis, translocation of pathogenic bacteria through an intestinal wall, endotoxaemia, or viral diarrhoea, in which the method includes orally or enterally administering to a patient in need of such treatment an effective amount of an exogenous nutritional preparation consisting essentially of at least one of free glutamic acid and ?-keto acid.

Abstract: The present invention relates to the use of glutamic acid for the preparation of a nutritional preparation that is intended for use for the treatment or prevention of excess or undesired permeability of the intestinal wall. In particular, according to the invention the glutamic acid is used in a nutritional preparation, such as a baby food or an enteral food. Examples of conditions where glutamic acid is used are: food allergy, internal drug allergy, sepsis, low blood flow through the intestines, ICU patients, surgical interventions, malnutrition or intestinal maturation of newborn babies.

Abstract: The invention relates to a process for the preparation of milk and milk powders having a long storage life utilizing techniques which are known per se. To that end, a milk liquid is prepared, which is evaporated, and a fat fraction is added to the milk liquid in one or more effects of the evaporator. This process is particularly suitable for the preparation of a milk having a long storage life, in which unsaturated fatty acid chains are present.